TET2 deficiency cooperates with CBFB-MYH11 to induce acute myeloid leukaemia and represents an early leukaemogenic event

Br J Haematol. 2022 Apr;197(2):201-206. doi: 10.1111/bjh.18027. Epub 2022 Feb 6.

Kristian Reckzeh^{1

2

3}, Montserrat Estruch^{1

2}, Mina Ali^{2

3}, Alexandra Søgaard Helbo⁴, Anna Mosbech⁵, Kyoung Jae Won^{2

3}, Frank Rücker⁶, Konstanze Döhner⁶, Kim Theilgaard-Mönch^{1

2

3

7}

¹ The Finsen Laboratory, Rigshospitalet/National Univ. Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
² Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
³ Novo Nordisk Foundation Centre for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁴ Novo Nordisk Foundation, Copenhagen, Denmark.
⁵ Alk Abelló, Hørsholm, Denmark.
⁶ Department of Internal Medicine III, University Hospital of Ulm, University of Ulm, Ulm, Germany.
⁷ Department of Hematology, Rigshospitalet/National Univ. Hospital, University of Copenhagen, Copenhagen, Denmark.

No abstract available

MeSH terms